Market Size of United States Pharmaceutical 3PL Industry
| Study Period | 2020 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2020 - 2022 |
| CAGR | 4.00 % |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
US Pharmaceutical 3PL Market Analysis
The US pharmaceutical third-party logistics market is expected to expand at a compound annual growth rate (CAGR) of more than 4% during the forecast period.
Due to COVID-19, the pharma supply chain was impacted by distribution challenges created by reduced transportation capacity. Disruptions at ports, quarantined crews, and labor shortages due to lockdowns are all contributing factors. COVID-19 caused the slowdown of the new pharmaceutical product development due to material shortages, disruptions in clinical trials, and backups in FDA approval.
However, the United States is the world's largest market for temperature-sensitive healthcare products such as biopharmaceuticals, vaccines, and clinical trial materials. The rising number of clinical trials employing various temperature-sensitive materials, such as blood samples, tissue samples, and some drugs, have catalyzed the growth of the market. There are many well-established pharmaceutical companies in the United States. The pharmaceutical industry of the United States alone accounts for almost half of the global pharmaceutical market.
Furthermore, the pharmaceutical 3PL industry is bound by strict rules and regulations. For instance, warehouses and shippers of pharmaceuticals in the United States must be registered with the Food and Drug Administration (FDA). There are no exceptions; even if they are planning a short-term or emergency relationship with a 3PL provider, one must make sure they are approved for storing and transporting pharmaceuticals. In addition, government regulations related to the distribution of pharmaceuticals are codified as part of the CGMPs (Current Good Manufacturing Practices), which is the best practice for the health and safety of consumers.
US Pharmaceutical 3PL Industry Segmentation
Pharmaceutical 3PL refers to the safe and efficient delivery of pharmaceutical drug products to benefit patient health. The US pharmaceutical 3PL market is segmented by function (domestic transportation management, international transportation management, and value-added warehousing and distribution) and supply chain (cold chain and non-cold chain). The report offers the market size and forecasts in value (USD billion) for all the above segments.
| Function | |
| Domestic Transportation Management | |
| International Transportation Management | |
| Value-added Warehousing and Distribution |
| Supply Chain | |
| Cold Chain | |
| Non-cold Chain |
United States Pharmaceutical 3PL Market Size Summary
The United States pharmaceutical third-party logistics (3PL) market is poised for significant growth, driven by its status as the largest market for temperature-sensitive healthcare products globally. The market's expansion is fueled by the increasing number of clinical trials involving temperature-sensitive materials, such as biopharmaceuticals and vaccines. Despite challenges posed by the COVID-19 pandemic, including supply chain disruptions and regulatory hurdles, the U.S. pharmaceutical industry remains a dominant force, accounting for a substantial portion of the global market. The industry is characterized by stringent regulations, with all pharmaceutical logistics providers required to comply with FDA standards and Current Good Manufacturing Practices (CGMPs) to ensure consumer safety.
The competitive landscape of the U.S. pharmaceutical 3PL market is marked by the presence of numerous international players, including Deutsche Post DHL, FedEx, and UPS, among others. These companies are actively expanding their capabilities to meet the growing demand for temperature-controlled logistics solutions. The market is expected to see further consolidation through mergers and acquisitions as companies strive to enhance their market share. The United States continues to lead in pharmaceutical sales, with significant contributions from major corporations like AbbVie and Johnson & Johnson. The country's strategic position as a key importer and exporter of pharmaceuticals, coupled with its advanced healthcare system, underscores its pivotal role in the global pharmaceutical supply chain.
United States Pharmaceutical 3PL Market Size - Table of Contents
-
1. MARKET INSIGHTS
-
1.1 Market Overview
-
1.2 Technological Trends
-
1.3 Government Regulations and Initiatives
-
1.4 Pharmaceutical E-commerce Market in United States
-
1.5 Spotlight on Packaging of Pharmaceuticals
-
1.6 Insights into Reverse/Return Logistics in the Pharma Industry
-
1.7 Industry Supply Chain/Value Chain Analysis
-
1.8 Impact of COVID-19 on the Market
-
-
2. MARKET SEGMENTATION (Market Size By Value)
-
2.1 Function
-
2.1.1 Domestic Transportation Management
-
2.1.2 International Transportation Management
-
2.1.3 Value-added Warehousing and Distribution
-
-
2.2 Supply Chain
-
2.2.1 Cold Chain
-
2.2.2 Non-cold Chain
-
-
United States Pharmaceutical 3PL Market Size FAQs
What is the current United States Pharmaceutical 3PL Market size?
The United States Pharmaceutical 3PL Market is projected to register a CAGR of greater than 4% during the forecast period (2024-2029)
Who are the key players in United States Pharmaceutical 3PL Market?
DHL, UPS, FedEx, Kuehne + Nagel and C. H. Robinson are the major companies operating in the United States Pharmaceutical 3PL Market.
